Oligonucleotide analysis: Practical implementation approaches for HPLC and LC-MS analyses

Register & watch

Thursday, April 23, 2020
15:00 to 16:00 CEST

Oligonucleotides represent a diverse class of therapeutics that provide great promise to treat disease, but can pose a number of analytical challenges to scientists. In this webinar, we will present:

  • Ion exchange and Reversed-Phase-Ion-Pair Approaches to the separation of Nucleic Acids
  • Separation examples of from small modified RNA, phosphothioated oligonucleotides, plasmid uncoiled and supercoiled DNA separations
  • Small scale purification options
  • LC/MS analysis of oligonucleotides

Thermo Scientific has over 20 years of innovations and publications around the separation of oligonucleotides, please join our webinar to learn how the DNAPac line of Ion Exchange and Reversed Phase columns can optimize and enhance your nucleic acid separations.

Register & watch

Presented by:

Dr. Ken Cook

Dr. Ken Cook is a bio-separations expert who began his career in as a biochemistry lecturer focused on protein chemistry and metabolism.

In well over 30 years of industry experience, Ken has covered a variety of analytical equipment, initially using HPLC, ion chromatography, SFC and capillary electrophoresis to develop new methods of analysis, including publications in a number of diverse fields. Currently, his role involves the support of Bio-Pharmaceutical applications to characterise protein and oligonucleotide-based bio-therapeutics as well as peptide mapping by LC/HRMS and charged variant analysis including novel coupling to MS. Recently, glycan analysis, aggregate analysis, on-line process monitoring and gene therapy characterisation is a growing interest.

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.